Ceregene is without a doubt trying to give the pd community what it needs as quickly as possible. Clinicians often can't fill their trials, [not ceregene] - recruitment is a big problem.

I don't like pointing this out, but most drugs don't make it [being proven in my ten years of advocacy]. This doesn't help to recruit anyone. Latest to be non-approved - KW-6002 - istradefylline.

People have been on that for years. Hopefully, they will go forward with it, but sometimes a person just can't be measured by paper stats. Take the drug away tho and then they can tell how efficacious it was....too late of course.

paula